Roidipedia.Compound reference & reporting
06 AUG 2026
CompoundsResearch chemical Isopropylnorsynephrine (Deoxy)
Research chemicalSympathomimetic amineBeta agonistSynephrine analog

Isopropylnorsynephrine (Deoxy)

Also known as Isopropyloctopamine · Deoxy · N-isopropyloctopamine · Isopropylnorsynephrine

Isopropylnorsynephrine (isopropyloctopamine, 'Deoxy') is a synthetic beta-adrenergic sympathomimetic marketed in topical and oral fat-loss products for targeted lipolysis. It has essentially no human safety data and carries the cardiovascular cautions of potent beta-agonists.

01 Overview

Isopropylnorsynephrine is a synthetic analog of octopamine/synephrine designed as a beta-adrenergic agonist. It appears in 'stubborn fat' serums and some oral fat-burners, promoted for localised lipolysis when applied to skin.

Human research is absent, and its beta-agonist activity raises concerns about heart rate and blood pressure, especially in oral use or when stacked with other stimulants.

02 Mechanism

Beta-adrenergic receptor agonist that stimulates lipolysis in fat cells and can increase heart rate and cardiac output.

03 Dosing

TierDoseRouteNotes
Oral (uncommon)25–50 mgOralRare oral use; safety unknown.
Topical100–250 mg/dayTransdermalApplied topically in 'stubborn fat' serums; no validated dose.

04 Effects

EffectMagnitudeEvidence
Localised lipolysisBeta-agonism may increase fat breakdown at application site.UnclearPreclinical

05 Side effects

EffectSeverityFrequencyEvidenceCountermeasures
TachycardiaBeta-agonist activity can raise heart rate, especially with oral use or stacking.ModerateUnquantifiedPreclinical
Blood pressure changesAdrenergic activity can alter blood pressure unpredictably.ModerateUnquantifiedPreclinical

07 References

Synthetic octopamine analogs in weight-loss productsPubMed

08 Discussion0 comments

?
Sign in to add a comment…
Create account
Discussion is moderated. No sourcing, vendor names or price talk — those comments are removed, and repeat posts are banned.
This page is reference information, not medical advice. Doses and protocols are documented as they appear in the clinical literature and in practice — describing them is not a recommendation to use them. Countermeasures listed here are not a substitute for a physician. Legal status varies by jurisdiction and changes.